Brainstorm to announce first quarter 2022 financial results and provide a corporate update

New york , may 2, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that the company will hold a conference call to update shareholders on financial results for the first quarter ended march 31, 2022, and provide a corporate update, at 8:00 a.m. eastern time on may 16, 2022.
BCLI Ratings Summary
BCLI Quant Ranking